The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Tarriff Scott since 2015.
This trader's CIK number is 1469124.
At the time of last reporting, Tarriff Scott was the CEO of Eagle Pharmaceuticals, Inc.. (stock ticker symbol EGRX).
Also see all insider trading activities at Eagle Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | EGRX | 0 | $0 | 101,864 | $1,833,118 | 0 | $0 |
| 2021 | EGRX | 0 | $0 | 0 | $0 | 31,201 | $273,944 |
| 2019 | EGRX | 0 | $0 | 111,057 | $5,017,018 | 0 | $0 |
| 2018 | EGRX | 0 | $0 | 0 | $0 | 237,908 | $961,148 |
| 2016 | EGRX | 0 | $0 | 63,674 | $3,768,501 | 0 | $0 |
| 2015 | EGRX | 0 | $0 | 216,222 | $12,555,277 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-11-01 | EGRX | Sale | 10,925 | 13.82 | 150,983 |
| 2023-11-02 | EGRX | Sale | 10,694 | 13.87 | 148,325 |
| 2023-10-02 | EGRX | Sale | 9,511 | 15.23 | 144,852 |
| 2023-10-03 | EGRX | Sale | 10,734 | 14.76 | 158,433 |
| 2023-05-16 | EGRX | Sale | 15,000 | 19.98 | 299,700 |
| 2023-05-15 | EGRX | Sale | 15,000 | 21.29 | 319,350 |
| 2023-05-12 | EGRX | Sale | 15,000 | 20.05 | 300,825 |
| 2023-05-11 | EGRX | Sale | 15,000 | 20.71 | 310,650 |
| 2021-04-01 | EGRX | Option Ex | 31,201 | 8.78 | 273,944 |
| 2019-04-01 | EGRX | Sale | 24,975 | 50.15 | 1,252,496 |
| 2019-03-01 | EGRX | Sale | 24,428 | 51.16 | 1,249,736 |
| 2019-02-01 | EGRX | Sale | 30,085 | 41.91 | 1,260,862 |
| 2019-01-02 | EGRX | Sale | 15,000 | 39.66 | 594,975 |
| 2019-01-03 | EGRX | Sale | 16,569 | 39.77 | 658,949 |
| 2018-06-28 | EGRX | Option Ex | 124,804 | 4.04 | 504,208 |
| 2018-03-30 | EGRX | Option Ex | 113,104 | 4.04 | 456,940 |
| 2016-04-01 | EGRX | Sale | 30,765 | 40.63 | 1,249,981 |
| 2016-02-01 | EGRX | Sale | 18,360 | 68.76 | 1,262,433 |
| 2016-01-04 | EGRX | Sale | 14,549 | 86.33 | 1,256,087 |
| 2015-12-01 | EGRX | Sale | 14,050 | 89.20 | 1,253,316 |
| 2015-11-02 | EGRX | Sale | 19,339 | 64.78 | 1,252,877 |
| 2015-10-01 | EGRX | Sale | 17,878 | 71.02 | 1,269,606 |
| 2015-09-01 | EGRX | Sale | 16,245 | 76.50 | 1,242,823 |
| 2015-08-03 | EGRX | Sale | 13,000 | 95.88 | 1,246,375 |
| 2015-07-01 | EGRX | Sale | 15,710 | 79.58 | 1,250,280 |
| 2015-03-20 | EGRX | Sale | 120,000 | 42.00 | 5,040,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tarriff Scott (CEO of Eagle Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.